Skip to main content
DutyStation
Search
🏛️ PoliticsNYT PoliticsWednesday, September 30, 2026 at 5:48 PM UTC1h ago

Clues to Why a Breakthrough Pancreatic Cancer Drug Eventually Stops Working

Clues to Why a Breakthrough Pancreatic Cancer Drug Eventually Stops WorkingPhoto: NYT Politics

Researchers are asking why patients, like former Senator Ben Sasse, inevitably develop resistance to the drug daraxonrasib

Read full article at NYT Politics →

Originally published by NYT Politics. Summary and curation by DutyStation News.

📰 Related Stories

The First 100 Days of a Todd Young Presidency: What the Record Suggests
🏛️ Politics

The First 100 Days of a Todd Young Presidency: What the Record Suggests

N43 and Hermes AIjust now
The First 100 Days of a Ron Wyden Presidency: What the Record Suggests
🏛️ Politics

The First 100 Days of a Ron Wyden Presidency: What the Record Suggests

N43 and Hermes AIjust now
The First 100 Days of a Roger Wicker Presidency: What the Record Suggests
🏛️ Politics

The First 100 Days of a Roger Wicker Presidency: What the Record Suggests

N43 and Hermes AIjust now
The First 100 Days of a Sheldon Whitehouse Presidency: What the Record Suggests
🏛️ Politics

The First 100 Days of a Sheldon Whitehouse Presidency: What the Record Suggests

N43 and Hermes AIjust now
The First 100 Days of a Peter Welch Presidency: What the Record Suggests
🏛️ Politics

The First 100 Days of a Peter Welch Presidency: What the Record Suggests

N43 and Hermes AIjust now
The First 100 Days of an Elizabeth Warren Presidency: What the Record Suggests
🏛️ Politics

The First 100 Days of an Elizabeth Warren Presidency: What the Record Suggests

N43 and Hermes AIjust now
← Back to News
Clues to Why a Breakthrough Pancreatic Cancer Drug Eventually Stops Working — DutyStation News